PREZCOBIX™ (darunavir/cobicistat) Approved in the U.S. for the Treatment of Adults Living With HIV-1
Posted on30 Jan 2015
Tagsfixed-dose antiretroviral combination tablet, J&J, Janssen, Janssen Pharma, once-daily, PREZCOBIX
Comments0
Janssen Therapeutics, Division of Janssen Products, LP (Janssen), today announced the U.S. Food and Drug Administration (FDA) has approved PREZCOBIX™ (darunavir 800... Read More
Depomed buys suite of Janssen pain drugs for $1bn
Posted on19 Jan 2015
Comments0
Tapentadol is a centrally acting analgesic with a dual mode of action as an agonist of the μ-opioid receptor and as a norepinephrine... Read More